AXGN
AxoGen, Inc. NASDAQ Listed Dec 17, 1986$44.84
+0.61%
vs $44.57
Mkt Cap $2.4B
52w Low $9.35
97.3% of range
52w High $45.83
50d MA $40.43
200d MA $30.40
P/E (TTM)
-131.9x
EV/EBITDA
10657.4x
P/B
16.0x
Debt/Equity
0.1x
ROE
-12.8%
P/FCF
-704.0x
RSI (14)
70.20
ATR (14)
$2.13
Beta
0.98
50d MA
$40.43
200d MA
$30.40
Avg Volume
1.1M
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
13631 Progress Boulevard · Alachua, FL 32615 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TNS | 0.12 | 0.07 | -41.7% | 41.99 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% | — |
| Feb 24, 2026 | TNS | 0.09 | 0.07 | -21.2% | 32.50 | -1.7% | -3.9% | +2.2% | -0.5% | -3.4% | -2.7% | — |
| Oct 29, 2025 | TNS | 0.09 | 0.12 | +33.3% | 22.25 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% | — |
| Aug 5, 2025 | TNS | 0.06 | 0.12 | +100.0% | 13.72 | +2.0% | +0.2% | +2.3% | -1.2% | +0.8% | +1.1% | — |
| May 8, 2025 | TNS | -0.01 | -0.02 | -100.0% | 12.59 | +2.2% | -9.7% | +0.2% | -4.5% | +8.6% | -0.3% | — |
| Feb 25, 2025 | TNS | 0.04 | 0.08 | +100.0% | 20.11 | +2.8% | -3.2% | -0.2% | +3.0% | -3.6% | -3.5% | — |
| Nov 7, 2024 | TNS | 0.01 | 0.07 | +1066.7% | 13.27 | +0.4% | -4.6% | +10.3% | -5.0% | -5.5% | -0.6% | — |
| Aug 8, 2024 | TNS | -0.05 | 0.05 | +200.0% | 10.70 | +4.2% | +3.0% | -1.4% | +3.6% | -4.5% | +2.5% | — |
| May 2, 2024 | TNS | -0.10 | -0.06 | +40.0% | 5.88 | +0.2% | -1.5% | -2.1% | +2.8% | +0.7% | +1.9% | — |
| Mar 5, 2024 | TNS | -0.09 | -0.06 | +33.3% | 8.99 | -0.9% | +0.8% | -0.4% | -3.0% | -3.5% | -2.5% | — |
| Nov 7, 2023 | TNS | -0.08 | 0.01 | +112.5% | 5.38 | -0.9% | +0.4% | -6.5% | -0.6% | +2.6% | +9.1% | — |
| Aug 7, 2023 | TNS | -0.15 | -0.03 | +80.0% | 8.28 | -2.5% | -19.4% | +0.2% | -6.5% | -2.9% | +0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 29 | Citizens | Maintains | Market Outperform → Market Outperform | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $41.99 | $41.52 | -1.1% | -0.5% | +3.4% | +0.2% | -1.5% | +2.6% |
| Apr 23 | Lake Street | Maintains | Buy → Buy | — | $37.00 | $37.32 | +0.9% | +1.1% | +4.9% | +0.4% | +6.6% | -0.5% |
| Mar 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $31.28 | $31.26 | -0.1% | +0.1% | +5.8% | +1.4% | +2.6% | -5.2% |
| Feb 24 | Citizens | Maintains | Market Outperform → Market Outperform | — | $35.38 | $29.62 | -16.3% | -8.1% | -3.9% | +2.2% | -0.5% | -3.4% |
| Dec 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.85 | $32.95 | +0.3% | +1.4% | -7.6% | -0.6% | -2.0% | -0.1% |
| Dec 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.85 | $32.95 | +0.3% | +1.4% | -7.6% | -0.6% | -2.0% | -0.1% |
| Dec 4 | Jefferies | Maintains | Buy → Buy | — | $28.33 | $31.07 | +9.7% | +16.0% | +1.4% | -7.6% | -0.6% | -2.0% |
| Dec 4 | Lake Street | Maintains | Buy → Buy | — | $28.33 | $31.07 | +9.7% | +16.0% | +1.4% | -7.6% | -0.6% | -2.0% |
| Oct 30 | Raymond James | Maintains | Outperform → Outperform | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| Oct 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| Oct 30 | Citizens | Maintains | Market Outperform → Market Outperform | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $22.25 | $22.91 | +3.0% | +1.9% | -2.0% | +4.6% | +2.2% | -1.6% |
| May 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.39 | $11.35 | -0.4% | -4.5% | +8.6% | -0.3% | +0.4% | -0.6% |
| Mar 5 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $18.62 | $18.60 | -0.1% | -2.2% | -2.4% | -0.2% | -3.2% | +1.5% |
| Mar 5 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $18.62 | $18.60 | -0.1% | -2.2% | -2.4% | -0.2% | -3.2% | +1.5% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.11 | $20.68 | +2.8% | -3.2% | -0.2% | +3.0% | -3.6% | -3.5% |
| Feb 26 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $20.11 | $20.68 | +2.8% | -3.2% | -0.2% | +3.0% | -3.6% | -3.5% |
| Feb 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $18.21 | $18.16 | -0.3% | -1.6% | +0.9% | +4.4% | -2.9% | -2.0% |
| Aug 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.70 | $11.15 | +4.2% | +3.0% | -1.4% | +3.6% | -4.5% | +2.5% |
| Jun 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.15 | $7.06 | -1.3% | -4.8% | +2.8% | +3.3% | +0.7% | +3.0% |
| Jan 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $8.14 | $8.22 | +1.0% | +7.9% | +3.0% | -2.0% | +3.8% | +3.4% |
| Dec 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.30 | $7.32 | +0.3% | +1.6% | +1.2% | +0.5% | -0.7% | +3.5% |
| Sep 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $4.99 | $4.88 | -2.2% | -6.2% | +6.8% | +1.2% | -1.2% | +0.0% |
| Aug 22 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $5.98 | $6.02 | +0.7% | +6.9% | +2.0% | -3.1% | +0.3% | +0.8% |
| May 10 | JMP Securities | Maintains | Market Outperform → Outperform | — | $9.32 | $9.44 | +1.3% | +1.8% | -3.4% | +0.5% | +0.1% | -0.2% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.22 | $9.16 | -0.7% | -2.5% | +1.3% | +1.3% | +2.4% | -0.5% |
| Mar 15 | JMP Securities | Maintains | Market Outperform → Outperform | — | $8.43 | $8.23 | -2.4% | -0.4% | -1.5% | -0.6% | +3.2% | +5.1% |
| May 9 | Canaccord Genuity | Upgrade | Hold → Buy | — | $9.03 | $8.81 | -2.4% | +3.2% | -0.1% | -9.5% | +5.1% | +6.1% |
| May 5 | SVB Leerink | Maintains | Outperform → Outperform | — | $8.26 | $9.05 | +9.6% | +18.3% | -7.6% | +3.2% | -0.1% | -9.5% |
| Nov 4 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $15.60 | $14.46 | -7.3% | -15.3% | +3.9% | +4.2% | -6.4% | -3.5% |
| May 6 | Canaccord Genuity | Maintains | Hold → Hold | — | $19.64 | $19.52 | -0.6% | +12.5% | +6.4% | -7.3% | -1.8% | -2.6% |
| Feb 23 | SVB Leerink | Maintains | Outperform → Outperform | — | $21.19 | $22.00 | +3.8% | +1.0% | +3.6% | -2.8% | +2.6% | +2.3% |
| Feb 23 | Canaccord Genuity | Maintains | Hold → Hold | — | $21.19 | $22.00 | +3.8% | +1.0% | +3.6% | -2.8% | +2.6% | +2.3% |
| Oct 23 | Guggenheim | Maintains | Buy → Buy | — | $13.35 | $13.99 | +4.8% | +1.4% | -5.5% | -2.0% | -2.8% | +4.4% |
| Aug 6 | SVB Leerink | Maintains | Outperform → Outperform | — | $12.31 | $13.00 | +5.6% | -2.2% | +1.5% | -4.0% | -3.5% | -0.4% |
| May 7 | Canaccord Genuity | Downgrade | Buy → Hold | — | $9.89 | $9.36 | -5.4% | -15.9% | +7.6% | -1.6% | -1.1% | -4.9% |
| Apr 2 | BTIG | Downgrade | Buy → Neutral | — | $8.68 | $8.23 | -5.2% | -4.7% | -7.1% | +7.2% | -3.0% | +3.1% |
| Nov 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $13.28 | $13.50 | +1.7% | +14.0% | +0.7% | +0.1% | +1.0% | -0.6% |
| Nov 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $13.28 | $13.50 | +1.7% | +14.0% | +0.7% | +0.1% | +1.0% | -0.6% |
| Aug 7 | William Blair | Downgrade | Outperform → Market Perform | — | $17.58 | $14.27 | -18.8% | -29.2% | +5.5% | +2.0% | +9.2% | +4.6% |
| Mar 25 | BTIG | Upgrade | Neutral → Buy | — | $20.41 | $21.30 | +4.4% | +4.9% | +0.5% | -4.7% | -0.1% | +2.9% |
| Mar 25 | BTIG Research | Upgrade | Neutral → Buy | — | $20.41 | $21.30 | +4.4% | +4.9% | +0.5% | -4.7% | -0.1% | +2.9% |
| Nov 14 | BTIG Research | Maintains | Neutral → Neutral | — | $33.28 | $33.12 | -0.5% | -3.3% | +2.5% | -3.1% | -11.2% | +3.3% |
| Oct 30 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $32.13 | $33.79 | +5.2% | +11.3% | +4.3% | +2.6% | -3.5% | -2.8% |
| May 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $39.80 | $38.50 | -3.3% | -3.6% | +2.2% | +5.9% | +2.4% | +1.5% |
| May 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $39.80 | $38.50 | -3.3% | -3.6% | +2.2% | +5.9% | +2.4% | +1.5% |
| Mar 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $29.20 | $31.00 | +6.2% | +16.3% | -2.9% | -1.1% | +1.1% | +4.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | Wendell Amy McBrideDir | — | Sell | 1,647 | $42.60 | $70K | 93,826 | -1.56% | +1.76% |
| May 7, 2026 | Quackenbush DorisOff | Sales VP | Sell | 3,878 | $43.51 | $169K | 92,416 | -3.02% | +0.10% |
| May 7, 2026 | Weiler Kathy JohnsonDir | — | Sell | 16,344 | $44.09 | $721K | — | -3.02% | +0.10% |
| May 7, 2026 | Hartley Lindsey MarieOff | CFO | Sell | 573 | $43.67 | $25K | 65,146 | -3.02% | +0.10% |
| May 7, 2026 | Hartley Lindsey MarieOff | CFO | Sell | 478 | $43.67 | $21K | 62,756 | -3.02% | +0.10% |
| May 7, 2026 | Kemp JensOff | Chief Marketing Officer | Sell | 4,000 | $43.44 | $174K | 72,451 | -3.02% | +0.10% |
| May 7, 2026 | JOHNSON JOHNDir | — | Sell | 11,050 | $43.26 | $478K | — | -3.02% | +0.10% |
8-K · 7.01
! Medium
Axogen, Inc. -- 8-K 7.01: Regulation FD Disclosure
Axogen disclosed a financial results presentation available for investor and analyst discussions, though the filing provides limited detail on specific business updates or financial performance metrics.
Apr 28
8-K · 7.01
! Medium
Axogen, Inc. -- 8-K 7.01: Regulation FD Disclosure
Axogen furnished a financial results presentation for potential use with analysts and investors, signaling routine investor communication and transparency regarding company performance.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 5,173,740 | $169M | Added | Dec 2025 |
| 2 | Vanguard Capital Management Llc | 2,291,563 | $76M | New | Mar 2026 |
| 3 | Wasatch Advisors Lp | 1,857,350 | $62M | Added | Mar 2026 |
| 4 | Assenagon Asset Management S.a. | 1,381,263 | $46M | — | Mar 2026 |
| 5 | Fmr Llc | 1,314,020 | $44M | Added | Mar 2026 |
| 6 | Divisadero Street Capital Management, Lp | 1,095,881 | $36M | Added | Mar 2026 |
| 7 | Next Century Growth Investors Llc | 865,963 | $29M | Added | Mar 2026 |
| 8 | Millennium Management | 787,254 | $26M | Reduced | Mar 2026 |
| 9 | First Eagle Investment Management, Llc | 709,180 | $23M | Reduced | Mar 2026 |
| 10 | Capricorn Fund Managers Ltd | 687,600 | $23M | New | Mar 2026 |
| 11 | Two Sigma Investments, Lp | 682,104 | $23M | Added | Mar 2026 |
| 12 | Soleus Capital Management, L.p. | 679,170 | $23M | Reduced | Mar 2026 |
| 13 | Vanguard Portfolio Management Llc | 488,807 | $16M | New | Mar 2026 |
| 14 | Bank Of America Corp /de/ | 466,824 | $15M | Added | Mar 2026 |
| 15 | Northern Trust Corp | 418,969 | $14M | Added | Mar 2026 |
| 16 | Connor, Clark & Lunn Investment Management Ltd. | 400,527 | $13M | Reduced | Dec 2025 |
| 17 | Tocqueville Asset Management L.p. | 384,900 | $13M | Reduced | Mar 2026 |
| 18 | Artemis Investment Management Llp | 349,888 | $12M | New | Mar 2026 |
| 19 | Highmark Wealth Management Llc | 344,940 | $11M | — | Mar 2026 |
| 20 | D.e. Shaw & Co | 265,009 | $9M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.38B
Enterprise Value
$2.05B
P/E (TTM)
-131.88x
Forward P/E
89.45x
PEG Ratio
-2.01x
P/B
16.03x
P/S
9.17x
P/FCF
-704.02x
EV/EBITDA
10657.37x
Shares Out
46.1M
Financials (TTM)
Revenue
$225.2M
Net Income
-$15.7M
EBITDA
$192K
Free Cash Flow
-$2.9M
Op Cash Flow
$812K
EPS Basic
$-0.34
EPS Diluted
$-0.34
EPS Forward
$0.50
Gross Margin
74.3%
Op Margin
-3.5%
Net Margin
-7.0%
Balance Sheet
Total Assets
$221.7M
Total Liab.
$92.8M
Total Equity
$128.8M
Cash
$35.5M
LT Debt
$16.9M
Book Value/Sh
$2.80
Debt/Equity
0.15x
Current Ratio
5.11
Quick Ratio
3.31
Returns & Growth
ROE
-12.8%
ROA
-10.9%
ROIC
-3.9%
Rev Growth YoY
+20.2%
EPS Growth YoY
-47.8%
Price Returns
2W
-3.6%
1M
-8.6%
3M
+24.4%
6M
+37.8%
12M
+262.5%
Technicals
52W High
$45.83
52W Low
$9.35
50d MA
$40.43
200d MA
$30.40
RSI (14)
70.20
ATR (14)
$2.13
Beta
0.98
Avg Volume
1.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
Jan 27, 2010
Analyst Price Targets
Consensus
$43.43
High
$50.00
Low
$36.00
Median
$40.00
Data updated apr 24, 2026 8:11pm
· Source: financialmodelingprep.com